Generic Name and Formulations:
Pentamidine isethionate 300mg/vial; lyophilized pwd for inhalation after reconstitution. To be used with the Respirgard II nebulizer.
Fresenius Kabi USA
Indications for NEBUPENT:
For prevention of Pneumocystis jiroveci pneumonia (PJP) in high-risk, HIV-infected patients defined by one or both of the following criteria: 1) a history of one or more episodes of PJP; 2) a peripheral CD4+ lymphocyte count ≤200/mm3.
>16yrs: 300mg once every 4 weeks administered via the Respirgard II nebulizer. Dose should be delivered until nebulizer chamber is empty (approx. 30–45 minutes).
≤16yrs: not recommended.
Exclude the presence of PJP before starting prophylaxis therapy. History of smoking or asthma. May induce bronchospasm/cough; administer inhaled bronchodilator prior to giving NebuPent dose; do not use Respirgard II nebulizer to administer a bronchodilator. Pregnancy (Cat. C). Nursing mothers: not recommended.
Do not mix with other drugs. Additive effects with concomitant other nephrotoxic drugs (eg, aminoglycosides, amphotericin B, cisplatin, foscarnet, vancomycin); monitor closely or avoid if possible.
Night sweats, GI upset, anemia, bronchitis, herpes, herpes zoster, flu, oral Candida, pharyngitis, sinusitis, upper respiratory tract infections, headache, chest pain, cough, wheezing, bad taste; monitor closely for serious adverse reactions: hypotension, hypoglycemia, hyperglycemia, hypocalcemia, thrombocytopenia, leukopenia, hepatic/renal dysfunction, ventricular tachycardia, pancreatitis (discontinue if occurs), Stevens-Johnson syndrome, hyperkalemia, abnormal ST segment; rare: extrapulmonary pneumocystosis.
Clinical Pain Advisor Articles
- Virtual Reality May Effectively Reduce Sensory, Affective, and Cognitive Pain During Labor
- Suprazygomatic Sphenopalatine Ganglion Block May Quickly Relieve Status Migrainosus Pain
- Reducing Mortality After Overdose: Is Treatment for Opioid Use Disorder Effective?
- A Physician's Guide to Incorporating Patient Spirituality in Practice
- Low Literacy Self-Management Program for Chronic Pain May Be Effective
- Neuropathic Pain Medications
- Higher Buprenorphine Dose May Not Increase Severity of Neonatal Abstinence Syndrome
- Terms Used for Addiction May Be Associated With Explicit, Implicit Bias
- Ketamine Infusions May Be Effective for Refractory Headache
- Physical, Psychosocial Activity May Be Protective Against Development of Chronic Pain in Older Adults
- The Challenge of Compassion in Modern Healthcare Settings
- Republican Opposition to Obamacare: What's Done, What's to Come
- Lowering Default Pill Counts in EMRs May Effectively Reduce Postoperative Opioid Prescription Numbers
- Steps Taken to Increase Use of Electronic Tools in Medicine
- Daily and Retrospective Pain Measurements Comparable in Hip Osteoarthritis